: Our Impact

{Photo Credit: Health for All Project Staff}Photo Credit: Health for All Project Staff

From January 30 to February 7, 2018, Angola’s Health for All (HFA) Project, supported by the U.S. Agency for International Development (USAID), welcomed global health expert, Dr. Alaine Nyaruhirira, for a week-long training on the use of GeneXpert – technology that has become a game-changer in the fight against tuberculosis (TB).

{Photo Credit: Health for All Project Staff}Photo Credit: Health for All Project Staff

From January 30 to February 7, 2018, Angola’s Health for All (HFA) Project, supported by the U.S. Agency for International Development (USAID), welcomed global health expert, Dr. Alaine Nyaruhirira, for a week-long training on the use of GeneXpert – technology that has become a game-changer in the fight against tuberculosis (TB).

{Photo Credit: Health for All Project Staff}Photo Credit: Health for All Project Staff

From January 30 to February 7, 2018, Angola’s Health for All (HFA) Project, supported by the U.S. Agency for International Development (USAID), welcomed global health expert, Dr. Alaine Nyaruhirira, for a week-long training on the use of GeneXpert – technology that has become a game-changer in the fight against tuberculosis (TB).

{Photo Credit: Health for All Project Staff}Photo Credit: Health for All Project Staff

From January 30 to February 7, 2018, Angola’s Health for All (HFA) Project, supported by the U.S. Agency for International Development (USAID), welcomed global health expert, Dr. Alaine Nyaruhirira, for a week-long training on the use of GeneXpert – technology that has become a game-changer in the fight against tuberculosis (TB).

{Photo Credit: Health for All Project Staff}Photo Credit: Health for All Project Staff

From January 30 to February 7, 2018, Angola’s Health for All (HFA) Project, supported by the U.S. Agency for International Development (USAID), welcomed global health expert, Dr. Alaine Nyaruhirira, for a week-long training on the use of GeneXpert – technology that has become a game-changer in the fight against tuberculosis (TB).

{Photo Credit: Liza Talukder}Jahidul Hasan works on the adverse drug event report.Photo Credit: Liza Talukder

The Directorate General of Drug Administration (DGDA)—with technical assistance from the USAID-funded SIAPS program, implemented by MSH—officially launched Bangladesh’s national pharmacovigilance (PV) program in 2013. After being first introduced at 20 private and public hospitals, and 13 pharmaceutical companies, the DGDA and SIAPS have organized trainings for focal persons to build their skills and knowledge on PV and increase adverse drug event (ADE) reporting.

{Photo Credit: Liza Talukder}Jahidul Hasan works on the adverse drug event report.Photo Credit: Liza Talukder

The Directorate General of Drug Administration (DGDA)—with technical assistance from the USAID-funded SIAPS program, implemented by MSH—officially launched Bangladesh’s national pharmacovigilance (PV) program in 2013. After being first introduced at 20 private and public hospitals, and 13 pharmaceutical companies, the DGDA and SIAPS have organized trainings for focal persons to build their skills and knowledge on PV and increase adverse drug event (ADE) reporting.

{Photo Credit: Liza Talukder}Jahidul Hasan works on the adverse drug event report.Photo Credit: Liza Talukder

The Directorate General of Drug Administration (DGDA)—with technical assistance from the USAID-funded SIAPS program, implemented by MSH—officially launched Bangladesh’s national pharmacovigilance (PV) program in 2013. After being first introduced at 20 private and public hospitals, and 13 pharmaceutical companies, the DGDA and SIAPS have organized trainings for focal persons to build their skills and knowledge on PV and increase adverse drug event (ADE) reporting.

{Photo Credit: Wezi Tjaronda}Olavi Shomongula shares his testimony with U.S. Ambassador to Namibia Thomas F. Daughton.Photo Credit: Wezi Tjaronda

A new electronic health tool developed by the USAID-funded Systems for Improved Access to Pharmaceuticals and Services (SIAPS) program, implemented byMSH, is being used in more than 50 public health facilities in Namibia. This tool—the Facility Electronic Stock Card (FESC)—has noticeably expedited the dispensing of medication to patients. This was evident when the US Ambassador to Namibia H.E. Thomas F. Daughton visited the Intermediate Hospital Oshakati (IHO), which is in the populous Oshana region in the North-Central part of Namibia.

{Photo Credit: Wezi Tjaronda}Olavi Shomongula shares his testimony with U.S. Ambassador to Namibia Thomas F. Daughton.Photo Credit: Wezi Tjaronda

A new electronic health tool developed by the USAID-funded Systems for Improved Access to Pharmaceuticals and Services (SIAPS) program, implemented byMSH, is being used in more than 50 public health facilities in Namibia. This tool—the Facility Electronic Stock Card (FESC)—has noticeably expedited the dispensing of medication to patients. This was evident when the US Ambassador to Namibia H.E. Thomas F. Daughton visited the Intermediate Hospital Oshakati (IHO), which is in the populous Oshana region in the North-Central part of Namibia.

Pages

Printer Friendly Version